UPDATE: FDA Warns Glaxo's Lamictal Can Cause Aseptic Meningitis
August 12 2010 - 12:29PM
Dow Jones News
The U.S. Food and Drug Administration said Thursday that
Lamictal, a medicine used to treat seizures in children, can cause
aseptic meningitis, an inflammation of the protective membranes
that cover the brain and spinal cord.
Lamictal, marketed by GlaxoSmithKline PLC, (GSK, GSK.LN), is
also used to treat bipolar disorder in adults. The FDA said it was
revising Lamictal's drug label to warn about the meningitis risk as
well as the medication guide that is given to patients.
"Aseptic meningitis is a rare but serious side effect of
Lamictal use," said Russell Katz, director of FDA's
neurology-products division. "Patients that experience symptoms
should consult their health-care professional immediately."
Symptoms of meningitis include headache, fever, stiff neck,
nausea, vomiting, rash, and sensitivity to light.
The FDA said its decision to revise the Lamictal label is based
on 40 cases of aseptic meningitis reported in patients taking
Lamictal from December 1994 to November 2009. Of the 40 patients,
35 were hospitalized. In most cases, the patients' symptoms
resolved after Lamictal was discontinued. In 15 cases, symptoms
returned when patients restarted Lamictal, according to FDA.
During the same time period, an estimated 46 million
prescriptions for Lamictal were dispensed.
The FDA said aseptic meningitis is diagnosed when tests of a
patient with signs and symptoms of meningitis don't detect bacteria
as the underlying cause of the illness.
-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294;
jennifer.corbett@dowjones.com
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024